Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Roche's $1.25B investment in U.S. facilities boosts drug manufacturing and diabetes tech, creating thousands of jobs.

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

May 12 (Reuters) - Roche Group (ROG.S), opens new tab said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio $700+ million investment will add 400+ high-wage manufacturing and 1,500 ...

Roche’s (OTCQX:RHHBY) Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The planned Holly Springs facility, spanning 700,000 ...